Cell Marque™ Primary Antibodies
Our Cell Marque™ antibody product line includes a comprehensive portfolio of primary antibodies suitable for immunohistochemistry (IHC) on formalin-fixed paraffin embedded tissue samples. We focus primarily on in vitro diagnostics (IVD), to provide established and novel antibodies, detection systems, and advanced ancillary reagents for clinical testing. With a medical team on staff, we are able to guarantee the performance and high quality of our antibodies, in order to supply you with the best care for your patients.
Cell Marque™ IHC products offer you innovation that can only come from a company whose focus for over 25 years has been geared toward producing medically relevant antibodies for clinical pathology. Our trusted Cell Marque™ antibodies are guaranteed to provide the most reproducible staining results.
Search for Cell Marque™ IHC antibodies either by antigen or by specialty. Specialty-specific clinical antibody categories include breast/gynecological pathology, dermatopathology, hematopathology, pediatric pathology, gastrointestinal (GI) pathology, cytopathology, pulmonary pathology, head & neck pathology, and other key areas.
Products
Related Resources
- Article: Immunohistochemistry: Current Applications in Breast Cancer
Immunohistochemistry (IHC) characterizes proteins in tissues, aiding in tumor subtype identification, tissue origin confirmation, and prognosis assessment.
- Brochure: A Comparative Study of IDH1 R132H
IDH1 R132H mutation aids in distinguishing gliomas and glioblastomas. A study compared two monoclonal antibodies for detecting this mutation.
- Brochure: Immuno Histo Chemistry
Cell Marque™ products join the Sigma-Aldrich® portfolio, enhancing tissue diagnostics. Volume 12 of the Reference Guide emphasizes IHC antibodies for clinical diagnostics.
- Brochure: Immunohistochemical Applications in Dermatopathology
Despite advances in immunohistochemistry, dermatopathology still relies on H&E stains. IHC can aid pathologists in detecting challenging cases.
- Brochure: Pediatric Malignancies and IHC
Pediatric tumors, especially "small round blue cell tumors," are diverse and challenging to detect. Effective diagnosis requires focused immunohistochemistry and comprehensive testing.
- Brochure: Anti-Ki-67 (MRQ-64) is a Reliable Rabbit Monoclonal IHC Marker
The Ki-67 antigen indicates cell proliferation and is used for grading various neoplasms. A study compared the novel MRQ-64 antibody to other clones using IHC on diverse tissues.
- Brochure: Special AT-rich sequence binding-protein 2 (SATB2)
Cancers of unknown primary (CUP) make up 3-5% of cases, often adenocarcinomas. IHC aids in diagnosis, but over 80% remain unidentified. Key antibodies include CK20, CDX-2, and SATB2 for colorectal and GI tract carcinomas.
To continue reading please sign in or create an account.
Don't Have An Account?